Myelolipoma is a rare tumor composed of fat and bone marrow components, most of which are located in the adrenal gland. Myelolipoma in the liver is extremely rare. To date, only 10 cases have been reported in the English-language medical literature. In one of these cases, the hepatic myelolipoma was found within a hepatocellular carcinoma (HCC). In the present study, we report the first case of the synchronous occurrence of hepatic myelolipoma and HCCs in different liver sections of one patient, a 26-year-old female who was admitted to our hospital because of a 4-d history of upper abdominal pain. The unenhanced computed tomography (CT) images showed a well-defined lowdensity mass with adipose components in the right liver lobe, 4.2 cm × 4.1 cm in size. Two inhomogeneous low- density masses were found in the left liver lobe, 8.6 cm × 7.7 cm and 2.6 cm × 2.6 cm in size. The masses in both the right and left liver lobes were heterogeneously enhanced in the contrast-enhanced CT images. Based on the results of the imaging examination, the mass in the right liver lobe was preliminarily considered to be a hamartoma, and the two masses in the left liver were preliminarily considered to be HCCs. We performed a right hepatectomy, a left hepatic lobectomy, and a cholecystectomy. Microscopic and immunohistochemical results revealed that the tumor in the right liver lobe was a hepatic myelolipoma, and that the two tumors in the left liver lobe were HCCs. 
INTRODUCTION
Myelolipoma is a rare benign tumor composed of fat and bone marrow components. The adrenal gland is the most common location [1, 2] . Myelolipoma in the liver is extremely rare. To our knowledge, 10 cases have been reported in the English-language medical literature as individual case reports [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . In one of the cases, the hepatic myelolipoma was found within a hepatocellular carcinoma (HCC) [6] . Hepatic myelolipomas are usually incidentally discovered by ultrasound (US), computed tomography (CT), magnetic resonance imaging (MRI), or autopsy examination. The first case of hepatic myelolipoma was reported in France by Grosdidier et al [13] in 1973, and it was found on a plain abdominal X-ray during a regular checkup for diabetes and obesity. Although hepatic imaging modalities will lead to detection of the tumor, the diagnosis of a hepatic myelolipoma has to be confirmed by a histopathologic examination of the resected specimen. In the present study, we present the eleventh case of hepatic myelolipoma to be reported in the English-language medical literature. This is also the first case of the synchronous occurrence of hepatic myelolipoma and HCCs in different liver sections of one patient. The clinical, imaging, and pathologic features of this case are described, and the subject of hepatic myelolipoma is briefly reviewed to deepen our understanding of it. Figure 1A ). Two inhomogeneous low-density masses were found in the left liver lobe, 8.6 cm × 7.7 cm and 2.6 cm × 2.6 cm in size ( Figure 1B and C). In the contrast-enhanced CT images, the masses in both the right and the left liver lobe were heterogeneously enhanced ( Figure 1D-F) . Based on the results of the imaging examination, the mass in the right liver lobe was preliminarily considered to be a hamartoma, and the two masses in the left liver lobe were preliminarily considered to be HCCs. After sufficient pre-operative preparation, a laparotomy was performed. One mass was found in the V section of the right liver lobe, and two masses were found in the left liver lobe, reflecting what was seen in the CT scan. We completed a right hepatectomy and a left hepatic lobectomy. Because the gallbladder was close to the tumor, a cholecystectomy was also performed. The intraoperative frozen pathology revealed that the tumor in the right liver lobe was a hepatic myelolipoma, and that the two tumors in the left liver lobe were HCCs.
CASE REPORT
Macroscopically, the mass in the right liver lobe had a solid capsule that was 5.0 cm × 4.0 cm. The two masses in the left liver lobe were solid and were 9.5 cm × 6.5 cm × 5 cm and 3.2 cm × 2.0 cm in size, respectively. Microscopically, the tumor in the right liver lobe consisted of adipose tissue and hematopoietic elements containing erythroid tissue, megakaryocytes and myeloid colonies, consistent with a myelolipoma (Figure 2A and B) . Tumor cells The etiology of hepatic myelolipoma remains uncertain. An ectopic adrenal gland is one hypothesis [8] . Most myelolipomas are reported in the adrenal gland. Anatomically, the right adrenal gland is adjacent to the right lobe of the liver, and an ectopic adrenal gland rarely appears in liver parenchyma [8] . Except for two cases, hepatic myelolipomas were found in the subcapsular region of the right liver lobe, including in our case. Emboli from bone marrow represent another hypothesis for the histogenesis of these lesions [4] . Although the gross appearance of a myelolipoma suggests a neoplastic origin, light and electron microscopy studies have revealed the polyclonal character of the hematopoietic cells [26] .
The definitive stimulus that causes the hematopoietic and fat cells to proliferate remains enigmatic. Several studies have suggested that tissue necrosis is the basic stimulus [6, 26] . For example, Van Hoe et al [6] speculated that the presence of foci of tumor necrosis may be associated with the development of a myelolipoma. Malignant tumors, hypertension, obesity, burns, and endocrinopathies have also been reported to be associated with the development of a myelolipoma [26] . The preoperative diagnosis of a hepatic myelolipoma is challenging. The appearance of myelolipomas on US, CT, and MRI images depends on the proportions of fat relative to myelogenous components [6] . US imaging reveals the myelolipoma to be a hyperechoic lesion [5, 8] . Unenhanced CT images usually show in the left liver lobe were in a funicular arrangement and showed invasive growth with significant atypia, compatible with malignant hepatic cancers ( Figure 2C and D). Immunohistochemical investigation showed that hepatocyte and CD34 proteins were positive in the tumors of the left liver lobe (Figure 3 ), while AFP, GPC-3, HMB45, Melan-A and SMA were negative. Finally, the tumor in the right liver lobe was diagnosed as a hepatic myelolipoma, and the tumors in the left liver lobe were diagnosed as HCCs. After surgery, the patient developed an intra-abdominal infection and was hospitalized for 27 d. Unfortunately, two months later, a CT scan of the liver suggested the recurrence of the HCC. The patient received four transcatheter arterial chemoembolization (TACE) procedures and one iodine 131I metuximab injection in our hospital. However, the HCC metastasized to the lung eight months after surgery. The patient was then lost after nine months of follow-up.
DISCUSSION
Myelolipoma is a rare type of benign, nonfunctioning tumor of mesenchymal origin, which is composed of various proportions of fat and hematopoietic cells [14] . As such, it resembles a site of extramedullary hematopoiesis. The adrenal gland is the most common site of myelolipomas; autopsy series have revealed the prevalence of myelolipomas in the adrenal gland at autopsy to be 0.08%-0.8% [2, 15, 16] . Extraadrenal myelolipomas are very rare [17] . They have been reported in the parietal pleura [18] , presacral area [19] , intrathoracic paravertebral area [20] , mediastinum [21, 22] , gastric antrum [23] , perirenal tissue [24] , and right iliac fossa [25] . To date, only ten cases of hepatic myelolipomas have been reported in the Englishlanguage medical literature [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] (Table 1 ). In one of these cases, the hepatic myelolipoma was found in a HCC [6] . In the present study, we report the first case of the synchronous occurrence of hepatic myelolipoma and HCCs in different liver sections of one patient. Table 2 that the tumor is well-encapsulated and has lowdensity areas varying from -69 to 28 HU as a result of intratumoral hemorrhage and varying proportions of fat and bone marrow elements [6, 9] . On enhanced CT images, the tumor appears moderately enhanced. The area of low density remains hypoattenuated [27] . On T1-weighted MR images, the mass usually appears well marginated with a capsule, shows heterogeneous hyperintensity and contains necrosis. Hepatic arteriography reveals a hypervascular mass with an avascular zone [8, 11] . On T2-weighted images, the mass shows heterogeneous low-signal intensity. After the administration of a gadolinium bolus, the lesion may show delayed heterogeneous enhancement [5, 28] . Hepatic myelolipoma should be distinguished from other hepatic lesions that cause lipomatous masses, including lipomas, angiomyolipomas, metastatic dermoid tumors, Langerhans cell histiocytosis, and focal fatty infiltration [29] . Areas of fatty degeneration can also be observed occasionally in HCCs and hepatic adenomas [30] . Although myelolipomas are benign, these types of tumor can be symptomatic and may increase in size. Thus, surgical intervention is warranted when the tumor is symptomatic or difficult to diagnose. In the present study, the hepatic myelolipoma could not be preoperatively diagnosed precisely. Furthermore, two HCCs were synchronously found in the left liver lobe. HCC is the sixth most common malignancy worldwide and has the third highest mortality among cancer patients [31, 32] , for whom surgical resection is the most common and effective therapeutic method. Accordingly, we performed a right hepatectomy and a left hepatic lobectomy to completely resect the hepatic myelolipoma and HCCs. Because the gallbladder was close to the tumor, a cholecystectomy was also performed. Histopathologic and immunohistochemical analyses of the surgical specimen confirmed the diagnosis of hepatic myelolipoma and HCCs. Microscopically, the hepatic myelolipoma was composed of fat cells and hematopoietic cells, including mature and developing myeloid, erythroid, and megakaryocytic cells. Marrow-like areas were also clearly observed.
In conclusion, hepatic myelolipoma is extremely rare. To our knowledge, only 10 cases have been [3] 2016 F/72 Asymptomatic Right liver lobe US, CT, CEUS Solitary 3.5 NA Radhi [4] 2010 M/76 Symptoms related to a urinary tract infection Segment VIII of the right liver US, CT Solitary 3.2 NA Savoye-Coll et al [5] 2000 M/25 Asymptomatic Segment IV MRI Solitary 9.0 Left hepatectomy
Van et al [6] 1994 M/57 Asymptomatic Right liver lobe US, CT Solitary 1.4 Hemihepatectomy Moreno et al [7] 1991 M/40 Malaise, anorexia, fever (27.27) reported in the English-language medical literature. In one of these cases, the myelolipoma was found within a HCC. In the present study, we report the first case of the synchronous occurrence of hepatic myelolipoma and HCCs in different liver sections of one patient, who received a right hepatectomy, a left hepatic lobectomy, and a cholecystectomy.
COMMENTS

Case characteristics
A 26-year-old female was admitted to our hospital because of a 4-d history of upper abdominal pain.
Clinical diagnosis
Abdomen was soft, lax, and non-distended, with no palpable mass.
Differential diagnosis
Differential diagnoses included lipomas, angiomyolipomas, metastatic dermoid tumor, and Langerhans cell histiocytosis. 
Laboratory diagnosis
Imaging diagnosis
The unenhanced computed tomography (CT) images showed a well-defined low-density mass with adipose components in the right liver lobe, 4.2 cm × 4.1 cm in size. Two inhomogeneous low-density masses were found in the left liver lobe, 8.6 cm × 7.7 cm and 2.6 cm × 2.6 cm in size. In the contrast-enhanced CT images, the masses in both the right and left liver lobes were heterogeneously enhanced. Based on the results of the imaging examination, the mass in the right liver lobe was preliminarily considered to be a hamartoma, and the two masses in the left liver lobe were preliminarily considered to be hepatocellular carcinoma (HCC).
Pathological diagnosis
Macroscopically, the two masses in the left liver lobe were solid and were 9.5 cm × 6.5 cm × 5 cm and 3.2 cm × 2.0 cm in size, respectively. The mass in the right liver lobe had a capsule, was solid and 5.0 cm × 4.0 cm in size. Microscopically, the tumor in the right liver lobe consisted of adipose tissue and hematopoietic elements containing erythroid tissue, megakaryocytes and myeloid colonies, which was consistent with a myelolipoma. The tumor cells in the left liver lobe were in a funicular arrangement and had invasive growth with significant atypia, which was compatible with malignant hepatic cancer. Immunohistochemical investigation showed that hepatocyte and CD34 proteins were positive in the tumors of the left liver lobe, while AFP, GPC-3, HMB45, Melan-A, and SMA were negative. Finally, the tumor in the right liver lobe was diagnosed as a hepatic myelolipoma, and the tumors in the left liver lobe were diagnosed as HCCs.
Treatment
The authors performed a right hepatectomy, a left hepatic lobectomy and a cholecystectomy.
Related reports
Hepatic myelolipoma is extremely rare. To date, only 10 cases have been reported in the English-language medical literature.
Experiences and lessons
In the present study, the authors present the first case of the synchronous occurrence of hepatic myelolipoma and HCCs in different liver sections of one patient. Preoperative diagnosis of hepatic myelolipoma is challenging. Surgery is the most effective treatment for the tumor.
Peer-review
This study highlights the diagnosis and treatment of the first case of the synchronous occurrence of hepatic myelolipoma and HCCs in different liver sections of one patient. This study also presents a literature review to deepen our understanding of hepatic myelolipoma. The information included is worthwhile to the reader.
